CIK 0001644963
- Non-accelerated filer
- Smaller reporting company
AVENUE THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATXI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474113275
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- 4 Open-market buy Director bought 2,000 shares at $5.11 ($10,220)
- 4 Open-market buy Director bought 5,000 shares at $5.46 ($27,300)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 8,850 shares at an average $5.88 ($52,045)
- 4 Open-market buy Director bought 650 shares at $5.91 ($3,842)
- 4 Open-market buy Director bought 10,000 shares at an average $5.90 ($58,999)
- 4 Open-market buy Director bought 15,000 shares at an average $5.24 ($78,554)
- 4 Gift VP Finance & Corp. Controller gave 30,000 shares (gift)
- 4 Gift President, CEO gave 250,000 shares (gift)
- 4 Gift Director gave 14,663 shares (gift)
- 4 Gift Director gave 14,663 shares (gift)
- 4 Gift Director gave 14,663 shares (gift)
- 4 Gift Interim Chief Medical Officer gave 10,000 shares (gift)
- 4 Gift Director gave 14,663 shares (gift)
- 4 Gift Director gave 14,663 shares (gift)
- 4 Gift Director gave 14,663 shares (gift)
- 4 Grant or award VP Finance & Corp. Controller acquired 1,351 shares (grant or award)
- 4 Grant or award President, CEO acquired 5,000 shares (grant or award)
- 4/A Open-market buy Director bought 50,000 shares at an average $4.28 ($214,143)
Page 4 of 5 · 96 filings